Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).

Name: Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Author: Herschorn, Sender

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER). — المؤلف: Herschorn, Sender — Health and quality of life outcomes 20180816

المؤلف: Herschorn, Sender
النشر: Health and quality of life outcomes 20180816
الوصف: 69 p.
الموضوعات: Acetanilides؛ Adult؛ Aged؛ Cross-Over Studies؛ Double-Blind Method؛ Female؛ Humans؛ Male